Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hertl

Showing results (21-30 of 237) with videos related to

Pageof 24
Sort By:
Archives of Dermatology|July 20, 2011
Rituximab for severe mucous membrane pemphigoid: safe enough to be drug of first choice?Michael Hertl, Philippe Bernard, Luca Borradori
The Journal of Clinical Investigation|May 4, 2006
T cell control in autoimmune bullous skin disordersMichael Hertl, Rüdiger Eming, Christian Veldman
Dermatology (Basel, Switzerland)|April 27, 2007
Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus?Michael Hertl, Rüdiger Eming, Luca Borradori
The Journal of Investigative Dermatology|January 17, 2009
B-cell-directed therapy for inflammatory skin diseasesAngela Nagel, Michael Hertl, Rüdiger Eming
Therapeutische Umschau. Revue Therapeutique|September 1, 2010
[Autoimmune bullous skin disorders]Michael Hertl, Andrea Niedermeier, Luca Borradori
Dermatologie (Heidelberg, Germany)|November 14, 2024
[Skin fragility in autoimmune blistering diseases of the skin]Farzan Solimani, Dario Didona, Michael Hertl
Italian Journal of Dermatology and Venereology|July 9, 2024
Ostraceous psoriasis in a male patient with AIDSDario Didona, Jacqueline Kussini, Michael Hertl
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 17, 2009
[Scaling erythemas in an infant]Simone Heimann, Michael Hertl, Jan Skrzypek
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 20, 2021
Laudatio zum 80. Geburtstag von David R. Bickers, M.DMichael Hertl, Jean Krutmann, Hans Merk
Immunology|September 20, 2008
Desmoglein 3-specific T regulatory 1 cells consist of two subpopulations with differential expression of the transcription factor Foxp3Christian Veldman, Andreas Pahl, Michael Hertl
Pageof 24

Showing results (21-30 of 237) with videos related to

Sort By:
Pageof 24
Archives of Dermatology|July 20, 2011
Rituximab for severe mucous membrane pemphigoid: safe enough to be drug of first choice?Michael Hertl, Philippe Bernard, Luca Borradori
The Journal of Clinical Investigation|May 4, 2006
T cell control in autoimmune bullous skin disordersMichael Hertl, Rüdiger Eming, Christian Veldman
Dermatology (Basel, Switzerland)|April 27, 2007
Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus?Michael Hertl, Rüdiger Eming, Luca Borradori
The Journal of Investigative Dermatology|January 17, 2009
B-cell-directed therapy for inflammatory skin diseasesAngela Nagel, Michael Hertl, Rüdiger Eming
Therapeutische Umschau. Revue Therapeutique|September 1, 2010
[Autoimmune bullous skin disorders]Michael Hertl, Andrea Niedermeier, Luca Borradori
Dermatologie (Heidelberg, Germany)|November 14, 2024
[Skin fragility in autoimmune blistering diseases of the skin]Farzan Solimani, Dario Didona, Michael Hertl
Italian Journal of Dermatology and Venereology|July 9, 2024
Ostraceous psoriasis in a male patient with AIDSDario Didona, Jacqueline Kussini, Michael Hertl
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 17, 2009
[Scaling erythemas in an infant]Simone Heimann, Michael Hertl, Jan Skrzypek
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 20, 2021
Laudatio zum 80. Geburtstag von David R. Bickers, M.DMichael Hertl, Jean Krutmann, Hans Merk
Immunology|September 20, 2008
Desmoglein 3-specific T regulatory 1 cells consist of two subpopulations with differential expression of the transcription factor Foxp3Christian Veldman, Andreas Pahl, Michael Hertl
Pageof 24